Menopause in the spotlight: important research and clinical advances - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Highlighting Menopause: Key Research Developments and Clinical Progress

  • June 16, 2026

Share

  • 1

    Menopause research has been historically underfunded, but recent years have seen increased attention and funding.

  • 2

    Up to 80% of individuals experience vasomotor symptoms during menopause, which can last from 4 to over 10 years.

  • 3

    New treatments, including neurokinin 3 receptor antagonists, have been developed for managing moderate-to-severe vasomotor symptoms.

  • 4

    Research highlights the need for personalized treatment plans based on individual risk factors and symptom severity.

  • 5

    Continued research is essential to expand treatment options and improve care for those affected by menopause.

Original Source(s)

Menopause in the spotlight: important research and clinical advances

  • June 16, 2026

Related Content

Editorial: Sex hormones and cardiovascular-renal health: mechanisms, consequences, and therapeutic insights

On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study

Why Is Vaginal Estrogen Still Underused?

A large Epic Cosmos analysis linked vaginal estrogen prescribing with lower rates of sepsis, hospital admission, and death following recurrent urinary tract infection, but researchers cautioned that prescribing may also mark broader differences in care.